The Pharma Legal Handbook: Uruguay

Uruguay is a small but commercially stable pharmaceutical market in South America with a well-regarded regulatory framework administered by the Ministry of Public Health (MSP). Uruguay's political and economic stability make it an attractive market for companies building a Southern Cone presence, and its regulatory system is generally considered transparent and predictable.

Uruguay's national health system provides broad access to medicines through the Fondo Nacional de Recursos and the health provider system, creating defined public procurement channels for companies with products on the covered conditions list. The MSP manages product registration, pricing notifications, and post-market surveillance.

The Pharma Legal Handbook: Uruguay provides a structured reference for pharmaceutical regulation in Uruguay, covering MSP product registration, pricing frameworks, clinical trial requirements, pharmacovigilance obligations, manufacturing standards, marketing rules, and intellectual property protection.